BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10807707)

  • 1. Rapidly growing periodontal enlargement.
    Manganaro AM; Phillips KM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 May; 89(5):535-8. PubMed ID: 10807707
    [No Abstract]   [Full Text] [Related]  

  • 2. Painless, rapidly increasing maxillary swelling and erythematous mucosa: differential diagnosis and therapy.
    Rullo R; Addabbo F; Festa VM
    J Can Dent Assoc; 2012; 78():c50. PubMed ID: 22673215
    [No Abstract]   [Full Text] [Related]  

  • 3. Burkitt's lymphoma: a problem in dental diagnosis.
    Pullon PA; Wexler DN
    ASDC J Dent Child; 1975; 42(3):213-6. PubMed ID: 1097483
    [No Abstract]   [Full Text] [Related]  

  • 4. Conventional dose intensive immunochemotherapy regimen in an adult patient with very late relapse of Burkitt's lymphoma.
    Italiano A; Peyrade F; Soler C; Cardot N; Thyss A
    J Chemother; 2007 Apr; 19(2):236-8. PubMed ID: 17434838
    [No Abstract]   [Full Text] [Related]  

  • 5. A rare cause of gastric malignancy: Burkitt's lymphoma.
    Doycheva I; Tanner S; Zhou D; Samadder NJ
    Endoscopy; 2013; 45 Suppl 2 UCTN():E432-3. PubMed ID: 24338176
    [No Abstract]   [Full Text] [Related]  

  • 6. Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology.
    Okudaira T; Nagasaki A; Miyagi T; Taira T; Ohshima K; Takasu N
    Intern Med; 2009; 48(6):475-8. PubMed ID: 19293550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-adjusted EPOCH-R for Burkitt lymphoma.
    Hoelzer D
    Clin Adv Hematol Oncol; 2014 Nov; 12(11):777-9. PubMed ID: 25674718
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary extranodal B-cell non-Hodgkin lymphoma mimicking an endodontic lesion: report of 2 cases.
    Wong GB; Spadafora S; Barbon N; Caputo M
    J Can Dent Assoc; 2013; 79():d93. PubMed ID: 24059491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary gastric lesion in Berkitt-like lymphoma].
    Zvonkov EE; Boriakh EA; Magomedova AU; Kravchenko SK; Kremenetskaia AM; Obukhova TN; Kaplanskaia IB; Samoĭlova RS; Makhinia VA; Shavlokhov VS; Krasil'nikova BB; Egorova EK; Danishian KI
    Ter Arkh; 2005; 77(7):85-8. PubMed ID: 16116918
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment with modified CHOP-rituximab in pediatric AIDS-related advanced stage Burkitt lymphoma.
    Crosswell HE; Bergsagel DJ; Yost R; Lew G
    Pediatr Blood Cancer; 2008 Apr; 50(4):883-5. PubMed ID: 17278123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Primary cutaneous follicle centre lymphoma: report of a case].
    Rong YF; He LM; Zhang YS; Feng YZ
    Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):769-70. PubMed ID: 24447559
    [No Abstract]   [Full Text] [Related]  

  • 12. [Burkitt's lymphoma--a case report].
    Obeid L; Schär B; Heitzmann F; Bargetzi M
    Praxis (Bern 1994); 1999 Sep; 88(36):1444-8. PubMed ID: 10500420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-adjusted EPOCH-R: a feasible alternative for Burkitt lymphoma in resource-constrained settings.
    Jindal N; Jain A; Lad D; Prakash G; Khadwal A; Malhotra P
    Br J Haematol; 2020 Sep; 190(6):e362-e363. PubMed ID: 32614462
    [No Abstract]   [Full Text] [Related]  

  • 14. How I treat Burkitt lymphoma in adults.
    Jacobson C; LaCasce A
    Blood; 2014 Nov; 124(19):2913-20. PubMed ID: 25258344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DA-EPOCH-R in Burkitt Lymphoma: Is It Enough for High-Risk Disease?
    Hertzberg M; Joske DJL; Gandhi MK
    J Clin Oncol; 2020 Nov; 38(31):3722-3723. PubMed ID: 32931401
    [No Abstract]   [Full Text] [Related]  

  • 16. Case report and review of immunodeficiency-associated Burkitt lymphoma.
    Johnson DH; Reske T; Ruiz M
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e121-5. PubMed ID: 25701328
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the protocol CMA reinforced in the treatment of endemic Burkitt lymphoma at CHU of Yopougon in Abidjan].
    Tolo-Diebkilé A; Koffi GK; Nanho CD; Sawadogo D; Kouakou B; Siransi-Bogui L; Ayémou R; Sanogo I
    Bull Cancer; 2010 May; 97(5):507-9. PubMed ID: 20071300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Burkitt's lymphoma of the ovary.
    Cyriac S; Srinivas L; Mahajan V; Sundersingh S; Sagar TG
    Afr J Paediatr Surg; 2010; 7(2):120-1. PubMed ID: 20431226
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in chemotherapy for large cell lymphoma.
    Coleman M; Gerstein G; Topilow A; Lebowicz J; Berhardt B; Chiarieri D; Silver RT; Pasmantier MW
    Semin Hematol; 1987 Apr; 24(2 Suppl 1):8-20. PubMed ID: 2438781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.